Navigation Links
Douglas A. Jabs, M.D., honored with Jackson Memorial Lecture by the American Academy of Ophthalmology
Date:10/13/2010

Douglas A. Jabs, MD, MBA, Professor and Chair of the Department of Ophthalmology, CEO of the Faculty Practice Associates, and Dean for Clinical Affairs at The Mount Sinai Medical Center, has been selected to deliver the prestigious Jackson Memorial Lecture at the 2010 Annual Meeting of the American Academy of Ophthalmology. The lecture will be published in the November issue of the American Journal of Ophthalmology.

In a presentation titled "Cytomegalovirus Retinitis and AIDS: Bench to Bedside," Dr. Jabs will discuss clinical and molecular research over the last 20 years on cytomegalovirus (CMV) retinitis, a viral inflammation in the retina, in people with AIDS. He will provide a synthesis of what researchers have learned about the pathogenesis of CMV retinitis and its interaction with HIV, reviewing several major epidemiologic studies.

"The data we have collected over the years has helped us better understand the behavior of cytomegalovirus retinitis at the molecular level, and bring that knowledge to the clinical setting," said Dr. Jabs. "Understanding the virology of this opportunistic infection and how it interacts with HIV will help us develop optimal paradigms for treating it."

A leading expert in inflammatory disorders of the eye, Dr. Jabs has co-authored more than 200 publications and 40 book chapters. His primary research interests include the treatment of uveitis, or the inflammation of the uvea in the eye, and ocular complications associated with AIDS and autoimmune diseases. He is chair of the Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, which is conducting clinical trials of treatments for severe uveitis, and the Studies of Ocular Complications of AIDS (SOCA) Research Group, which has conducted several randomized, multicenter, controlled trials on CMV retinitis and a long-term cohort study of the ocular complications of AIDS in the current era.

"We are proud that the American Academy of Ophthalmology has recognized Dr. Jabs and his work in CMV retinitis and AIDS," said Dennis Charney, M.D., Anne and Joel Ehrenkranz Dean of Mount Sinai School of Medicine and Executive Vice President for Academic Affairs at The Mount Sinai Medical Center. "His commitment to ground-breaking translational research in ophthalmology makes him a true asset to Mount Sinai and to the field."

Prior to joining Mount Sinai, Dr. Jabs was the Alan C. Woods Professor of Ophthalmology and Professor of Medicine at The Johns Hopkins University School of Medicine, Professor of Epidemiology at The Johns Hopkins University Bloomberg School of Public Health, and the Director of the Division of Ocular Immunology at The Wilmer Eye Institute. After receiving his medical degree from The Johns Hopkins University School of Medicine he completed an internship in internal medicine at Cornell Medical Center/New York Hospital, a residency in internal medicine at The Johns Hopkins Hospital, a residency in ophthalmology at The Wilmer Eye Institute, and a fellowship in rheumatology at The Johns Hopkins Medical Institutions. In 1984, he joined the faculty at The Johns Hopkins University School of Medicine, where he remained until joining Mount Sinai in 2007.

Dr. Jabs has received several awards for his research and clinical accomplishments, including the Research to Prevent Blindness Olga Keith Wiess Scholar Award, the Research to Prevent Blindness Lew R. Wasserman Merit Award, the Research to Prevent Blindness Senior Scientific Investigator, the American Academy of Ophthalmology Achievement Award and Senior Achievement Award, and the Ethel Baxter Award for Excellence in Research from the Sjgren's Syndrome Foundation.

The Jackson Memorial Lecture is named for Dr. Edward Jackson, who helped establish the modern ophthalmology field. He helped create the American Board of Ophthalmology and developed its first board examination. He also helped pave the way for future medical conference both within Ophthalmology and in other fields by advocating for instructional courses at the annual meeting. Previous Jackson Memorial Lecturers include: Harry A. Quigley, MD, who spoke about Angle Closure Glaucoma; Frederick L. Ferris III, MD, whose lecture focused on the benefit of clinical trials beyond evaluating treatment effect; and Edwin M. Stone, MD, PhD, who discussed the role of genetic testing in finding a cure for Leber Congenital Amaurosis.

"I am honored and humbled to follow in the footsteps of the long line of research pioneers in ophthalmology who have delivered the Jackson Memorial Lecture," said Dr. Jabs. "I hope my presentation will help stimulate discussion of improving clinical outcomes in patients with AIDS and CMV retinitis."


'/>"/>

Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Related medicine news :

1. NRPA Launches National Hunger Relief Initiative at Indianapolis' Douglass Park
2. Consult A Doctor, Inc. Names Retail Clinic Pioneer, Douglas Smith, M.D. as Chief Medical Officer
3. O. Marion Burton, M.D., F.A.A.P., addresses American Academy of Pediatrics in new term as president
4. Anthony S. Fauci, M.D., on results from the CAPRISA 004 microbicide study
5. Renowned Psychiatrist, Lyubov Y Gorelik, M.D., is selected to represent New York in The Leading Physicians of the World
6. Gino Tutera, M.D., F.A.C.O.G. Brings SottoPelle Therapy to Middle Tennessee, Opens Practice in Nashville Medical District
7. Joan Miller, M.D., receives 2010 Leadership Award for the Advancement of Women Faculty
8. University of Utah afib specialist, Marcos Daccarett, M.D., wins Young Investigator Award
9. Nationally Known Interventional Neuroradiologist John Pile-Spellman, M.D., Joins Neurological Surgery, P.C.
10. AMA Honors Vice Admiral John Mateczun, M.D., With Top Government Service Award
11. Early transcatheter valve recipient honored with Courageous Patient Award at TCT 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... franchises from across the country gathered at the La Valencia Hotel in San ... PROSHRED Chicago was named the year’s most outstanding franchise, walking away with ...
(Date:2/5/2016)... ... 05, 2016 , ... Pivot Point Consulting, a leading national ... & Services for HIT Implementation Support & Staffing report with an outstanding score ... by healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Colorize ... from on one drop zone to the next using Colorize's dynamic moving camera. Colorize ... project. This package includes a 3D slideshow environment with 1 to 5 focus points ...
(Date:2/5/2016)... ... 05, 2016 , ... Calls Blacklist has just been updated by mobile app ... the developer has fixed known bugs within the app. Calls Blacklist allows its users ... not consuming any of their device’s battery power or memory. It provides a powerful ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Global Immunology Market to 2022 - Large ... growth Summary Immune-mediated inflammatory diseases are ... affect 5–7% of western populations. Although they are ... key patient demographics, they are pathophysiologically linked, being ... inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a ...
(Date:2/4/2016)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... treat life-threatening diseases, today announced results for the ... 2015. --> --> ... our last quarterly call, we strategically advanced pre-clinical ... to establish the Aethlon Hemopurifier® as a leading ...
Breaking Medicine Technology: